Additional bevacizumab in EGFR-mutant lung adenocarcinoma...

Additional bevacizumab in EGFR-mutant lung adenocarcinoma patients who had oligo-progression after the failure of EGFR-TKI: A single-institute retrospective study

Kashiwabara, Kosuke, Fujii, Shinji, Tsumura, Shinsuke, Sakamoto, Kazuhiko, Semba, Hiroshi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Year:
2020
Language:
english
Journal:
Cancer Treatment and Research Communications
DOI:
10.1016/j.ctarc.2019.100163
File:
PDF, 530 KB
english, 2020
Conversion to is in progress
Conversion to is failed